Description
BSE lists 3,71,000 new equity shares of Gujarat Terce Laboratories Limited issued on a preferential basis to promoters, effective February 25, 2026. Shares are subject to lock-in until June 16, 2027.
Summary
BSE Notice No. 20260224-9 informs trading members that 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code: 524314) have been listed and permitted to trade on the Exchange effective Wednesday, February 25, 2026. The shares were issued on a preferential basis to promoters at an issue price of Rs. 37.70 per share (face value Rs. 10 + premium of Rs. 27.70).
Key Points
- 3,71,000 equity shares of Rs. 10/- each issued at a premium of Rs. 27.70 to promoters on a preferential basis
- Issue price: Rs. 37.70 per share
- ISIN: INE499G01013
- Shares rank pari-passu with existing equity shares of the company
- Distribution numbers: 74,20,301 to 77,91,300
- Date of allotment: December 16, 2025
- Trading effective from February 25, 2026
Regulatory Changes
No regulatory changes. This is a standard listing notice for newly allotted securities under the preferential allotment route.
Compliance Requirements
- Trading members are informed to note the listing and permit trading in these new securities from February 25, 2026
- The entire allotment of 3,71,000 shares is subject to a lock-in period and cannot be freely traded until June 16, 2027
Important Dates
- Date of Allotment: December 16, 2025
- Trading Commencement Date: February 25, 2026
- Lock-in Expiry Date: June 16, 2027 (applicable to all 3,71,000 shares, Dist. Nos. 74,20,301 to 77,91,300)
Impact Assessment
The listing adds 3,71,000 shares to the tradable universe of Gujarat Terce Laboratories Limited (Scrip Code: 524314), representing a promoter preferential allotment. However, since all newly listed shares are under lock-in until June 16, 2027, there is no immediate increase in free-float or liquidity. Market impact is minimal and confined to the company’s existing shareholders and traders monitoring promoter shareholding changes.
Impact Justification
Routine listing of preferentially allotted shares to promoters with a lock-in period; limited broader market impact as it affects a single small-cap company.